ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 220 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,883 | -12.7% | 40,822 | -24.1% | 0.02% | -18.2% |
Q1 2023 | $2,157 | -20.9% | 53,798 | -8.6% | 0.02% | -24.1% |
Q4 2022 | $2,728 | -99.9% | 58,888 | -18.3% | 0.03% | -17.1% |
Q3 2022 | $2,986,000 | -43.2% | 72,109 | -0.5% | 0.04% | -31.4% |
Q1 2022 | $5,260,000 | +14.6% | 72,438 | +32.7% | 0.05% | +24.4% |
Q4 2021 | $4,590,000 | +6.3% | 54,581 | +14.0% | 0.04% | +2.5% |
Q3 2021 | $4,317,000 | +31.1% | 47,869 | -7.7% | 0.04% | 0.0% |
Q2 2019 | $3,294,000 | -4.5% | 51,877 | +4.4% | 0.04% | -7.0% |
Q1 2019 | $3,448,000 | +59.6% | 49,707 | 0.0% | 0.04% | +43.3% |
Q4 2018 | $2,161,000 | -28.6% | 49,707 | +25.3% | 0.03% | -16.7% |
Q3 2018 | $3,028,000 | -24.3% | 39,669 | -23.7% | 0.04% | -23.4% |
Q2 2018 | $3,999,000 | +47.7% | 52,021 | -2.0% | 0.05% | +42.4% |
Q1 2018 | $2,707,000 | +11.1% | 53,096 | +1.1% | 0.03% | +13.8% |
Q4 2017 | $2,436,000 | +8.3% | 52,522 | +24.4% | 0.03% | +7.4% |
Q3 2017 | $2,249,000 | -14.2% | 42,218 | 0.0% | 0.03% | -18.2% |
Q2 2017 | $2,622,000 | +21.3% | 42,218 | +32.4% | 0.03% | +22.2% |
Q1 2017 | $2,162,000 | -5.6% | 31,898 | -2.0% | 0.03% | -6.9% |
Q4 2016 | $2,290,000 | – | 32,564 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 38,100 | $2,928,000 | 1.67% |
Opaleye Management Inc. | 80,000 | $6,149,000 | 1.59% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 410,000 | $31,517,000 | 1.06% |
Opus Point Partners Management, LLC | 6,311 | $485,000 | 1.05% |
SECTOR GAMMA AS | 68,015 | $5,228,000 | 0.87% |
Capital Impact Advisors, LLC | 27,074 | $2,061,000 | 0.76% |
FORTALEZA ASSET MANAGEMENT INC/ | 1,130 | $87,000 | 0.71% |
CAPITAL INTERNATIONAL LTD /CA/ | 46,957 | $3,610,000 | 0.63% |
Virtus ETF Advisers LLC | 8,794 | $676,000 | 0.60% |
Rock Springs Capital Management LP | 200,000 | $15,374,000 | 0.59% |